It can mainly inhibit both wild type and mutant FLT3 at very low concentrations, as well as PDGFRa, which will increase the growth inhibitory effect, especially in peritumor tissue-derived cancer stem cells (p-CSC) [61]. The gene discussed is FLT3; the disease is cancer.